Nanobiotix (NBTX) Assets Average (2021 - 2025)
Nanobiotix (NBTX) posted Assets Average of $331.7 million for Q4 2025, down 15.89% on a QoQ basis from $394.4 million in Q4 2024, and down 15.89% year-over-year from $394.4 million in Q4 2024.
Nanobiotix (NBTX) has 4 years of Assets Average data on file, last reported at $331.7 million in Q4 2025.
- In Q4 2025, Assets Average fell 15.89% year-over-year to $331.7 million; the TTM figure through Dec 2025 stood at $331.7 million (down 15.89% YoY), while the FY2025 annual figure was $74.8 million, down 14.33% from the prior year.
- Assets Average eased to $331.7 million in Q4 2025, from $394.4 million in the prior quarter.
- Across five years, Assets Average topped out at $418.8 million in Q4 2023 and bottomed at $331.7 million in Q4 2025.
- A 4-year average of $385.0 million and a median of $394.8 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average rose 5.95% — and 2025, when it dropped 15.89%.
- Year by year, Assets Average stood at $395.3 million in 2022, then climbed by 5.95% to $418.8 million in 2023, then declined by 5.84% to $394.4 million in 2024, then slipped by 15.89% to $331.7 million in 2025.
- The last three Assets Average figures came in at $331.7 million (Q4 2025), $394.4 million (Q4 2024), and $418.8 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 2.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.01 Mn |
| Jun 30, 2025 | 61.59 Mn |
| Dec 31, 2024 | 82.69 Mn |
| Jun 30, 2024 | 97.19 Mn |
| Dec 31, 2023 | 72.51 Mn |
| Jun 30, 2023 | 52.49 Mn |
| Dec 31, 2022 | 73.50 Mn |
| Jun 30, 2022 | 101.23 Mn |
| Dec 31, 2021 | 132.82 Mn |
| Jun 30, 2021 | 154.51 Mn |